Table of Content

1 Gastrointestinal Stromal Tumor (GIST) Drug Market Overview
1.1 Gastrointestinal Stromal Tumor (GIST) Drug Product Scope
1.2 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type
1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Amcasertib
1.2.3 Anagrelide hydrochloride CR
1.2.4 APG-1351
1.2.5 Binimetinib
1.2.6 Others
1.3 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application
1.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price Trends (2016-2027)

2 Gastrointestinal Stromal Tumor (GIST) Drug Estimates and Forecasts by Region
2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2016-2021)
2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Estimates and Projections (2016-2027)
2.4.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Estimates and Projections (2016-2027)
2.4.3 China Gastrointestinal Stromal Tumor (GIST) Drug Estimates and Projections (2016-2027)
2.4.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Estimates and Projections (2016-2027)
2.4.6 India Gastrointestinal Stromal Tumor (GIST) Drug Estimates and Projections (2016-2027)

3 Global Gastrointestinal Stromal Tumor (GIST) Drug Competition Landscape by Players
3.1 Global Top Gastrointestinal Stromal Tumor (GIST) Drug Players by Sales (2016-2021)
3.2 Global Top Gastrointestinal Stromal Tumor (GIST) Drug Players by Revenue (2016-2021)
3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor (GIST) Drug as of 2020)
3.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Company (2016-2021)
3.5 Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2016-2021)
4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price Forecast by Type (2022-2027)

5 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2016-2021)
5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price Forecast by Application (2022-2027)

6 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures
6.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company
6.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company (2016-2021)
6.1.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2016-2021)
6.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type
6.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2022-2027)
6.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application
6.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application (2022-2027)

7 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures
7.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company
7.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company (2016-2021)
7.1.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2016-2021)
7.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type
7.2.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application
7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)

8 China Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures
8.1 China Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company
8.1.1 China Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company (2016-2021)
8.1.2 China Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2016-2021)
8.2 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type
8.2.1 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2022-2027)
8.3 China Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application
8.3.1 China 162 Sales Breakdown by Application (2016-2021)
8.3.2 China 162 Sales Breakdown by Application (2022-2027)

9 Japan Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures
9.1 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company
9.1.1 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company (2016-2021)
9.1.2 Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2016-2021)
9.2 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type
9.2.1 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures
10.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company
10.1.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type
10.2.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures
11.1 India Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company
11.1.1 India Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company (2016-2021)
11.1.2 India Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2016-2021)
11.2 India Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type
11.2.1 India Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2022-2027)
11.3 India Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application
11.3.1 India Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Gastrointestinal Stromal Tumor (GIST) Drug Business
12.1 Ariad Pharmaceuticals, Inc.
12.1.1 Ariad Pharmaceuticals, Inc. Corporation Information
12.1.2 Ariad Pharmaceuticals, Inc. Business Overview
12.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.1.5 Ariad Pharmaceuticals, Inc. Recent Development
12.2 Arog Pharmaceuticals, Inc.
12.2.1 Arog Pharmaceuticals, Inc. Corporation Information
12.2.2 Arog Pharmaceuticals, Inc. Business Overview
12.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.2.5 Arog Pharmaceuticals, Inc. Recent Development
12.3 Array BioPharma Inc.
12.3.1 Array BioPharma Inc. Corporation Information
12.3.2 Array BioPharma Inc. Business Overview
12.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.3.5 Array BioPharma Inc. Recent Development
12.4 Astex Pharmaceuticals, Inc.
12.4.1 Astex Pharmaceuticals, Inc. Corporation Information
12.4.2 Astex Pharmaceuticals, Inc. Business Overview
12.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.4.5 Astex Pharmaceuticals, Inc. Recent Development
12.5 Blueprint Medicines Corporation
12.5.1 Blueprint Medicines Corporation Corporation Information
12.5.2 Blueprint Medicines Corporation Business Overview
12.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.5.5 Blueprint Medicines Corporation Recent Development
12.6 Boston Biomedical, Inc.
12.6.1 Boston Biomedical, Inc. Corporation Information
12.6.2 Boston Biomedical, Inc. Business Overview
12.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.6.5 Boston Biomedical, Inc. Recent Development
12.7 Calithera Biosciences, Inc.
12.7.1 Calithera Biosciences, Inc. Corporation Information
12.7.2 Calithera Biosciences, Inc. Business Overview
12.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.7.5 Calithera Biosciences, Inc. Recent Development
12.8 Chipscreen Biosciences Ltd
12.8.1 Chipscreen Biosciences Ltd Corporation Information
12.8.2 Chipscreen Biosciences Ltd Business Overview
12.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.8.5 Chipscreen Biosciences Ltd Recent Development
12.9 Deciphera Pharmaceuticals, LLC
12.9.1 Deciphera Pharmaceuticals, LLC Corporation Information
12.9.2 Deciphera Pharmaceuticals, LLC Business Overview
12.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.9.5 Deciphera Pharmaceuticals, LLC Recent Development
12.10 F. Hoffmann-La Roche Ltd.
12.10.1 F. Hoffmann-La Roche Ltd. Corporation Information
12.10.2 F. Hoffmann-La Roche Ltd. Business Overview
12.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.10.5 F. Hoffmann-La Roche Ltd. Recent Development
12.11 Horizon Pharma Plc
12.11.1 Horizon Pharma Plc Corporation Information
12.11.2 Horizon Pharma Plc Business Overview
12.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.11.5 Horizon Pharma Plc Recent Development
12.12 Immunicum AB
12.12.1 Immunicum AB Corporation Information
12.12.2 Immunicum AB Business Overview
12.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.12.5 Immunicum AB Recent Development
12.13 Jiangsu Hengrui Medicine Co., Ltd.
12.13.1 Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
12.13.2 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
12.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.13.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Development
12.14 Kolltan Pharmaceuticals, Inc.
12.14.1 Kolltan Pharmaceuticals, Inc. Corporation Information
12.14.2 Kolltan Pharmaceuticals, Inc. Business Overview
12.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.14.5 Kolltan Pharmaceuticals, Inc. Recent Development
12.15 Natco Pharma Limited
12.15.1 Natco Pharma Limited Corporation Information
12.15.2 Natco Pharma Limited Business Overview
12.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.15.5 Natco Pharma Limited Recent Development
12.16 Nerviano Medical Sciences S.r.l.
12.16.1 Nerviano Medical Sciences S.r.l. Corporation Information
12.16.2 Nerviano Medical Sciences S.r.l. Business Overview
12.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.16.5 Nerviano Medical Sciences S.r.l. Recent Development
12.17 Novartis AG
12.17.1 Novartis AG Corporation Information
12.17.2 Novartis AG Business Overview
12.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.17.5 Novartis AG Recent Development
12.18 Omeros Corporation
12.18.1 Omeros Corporation Corporation Information
12.18.2 Omeros Corporation Business Overview
12.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
12.18.5 Omeros Corporation Recent Development

13 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Cost Analysis
13.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
13.4 Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
14.3 Gastrointestinal Stromal Tumor (GIST) Drug Customers

15 Market Dynamics
15.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Trends
15.2 Gastrointestinal Stromal Tumor (GIST) Drug Drivers
15.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
15.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2016-2021)
Table 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Region (2016-2021)
Table 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Company (2016-2021)
Table 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Company (2016-2021)
Table 16. Global Gastrointestinal Stromal Tumor (GIST) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumor (GIST) Drug as of 2020)
Table 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Type (2016-2021)
Table 23. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Type (2022-2027)
Table 26. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Type (2022-2027)
Table 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Application (2016-2021)
Table 31. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Application (2022-2027)
Table 35. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Application (2022-2027)
Table 37. Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2016-2021)
Table 40. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2021)
Table 44. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2022-2027)
Table 46. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2021)
Table 48. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2022-2027)
Table 62. China Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2016-2021)
Table 64. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company (2016-2021)
Table 66. China Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2021)
Table 68. China Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2022-2027)
Table 70. China Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2021)
Table 72. China Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2022-2027)
Table 98. India Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2016-2021)
Table 100. India Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company (2016-2021)
Table 102. India Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2021)
Table 104. India Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2022-2027)
Table 106. India Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2021)
Table 108. India Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2022-2027)
Table 110. Ariad Pharmaceuticals, Inc. Corporation Information
Table 111. Ariad Pharmaceuticals, Inc. Description and Business Overview
Table 112. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 114. Ariad Pharmaceuticals, Inc. Recent Development
Table 115. Arog Pharmaceuticals, Inc. Corporation Information
Table 116. Arog Pharmaceuticals, Inc. Description and Business Overview
Table 117. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 119. Arog Pharmaceuticals, Inc. Recent Development
Table 120. Array BioPharma Inc. Corporation Information
Table 121. Array BioPharma Inc. Description and Business Overview
Table 122. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 124. Array BioPharma Inc. Recent Development
Table 125. Astex Pharmaceuticals, Inc. Corporation Information
Table 126. Astex Pharmaceuticals, Inc. Description and Business Overview
Table 127. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 129. Astex Pharmaceuticals, Inc. Recent Development
Table 130. Blueprint Medicines Corporation Corporation Information
Table 131. Blueprint Medicines Corporation Description and Business Overview
Table 132. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 134. Blueprint Medicines Corporation Recent Development
Table 135. Boston Biomedical, Inc. Corporation Information
Table 136. Boston Biomedical, Inc. Description and Business Overview
Table 137. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 139. Boston Biomedical, Inc. Recent Development
Table 140. Calithera Biosciences, Inc. Corporation Information
Table 141. Calithera Biosciences, Inc. Description and Business Overview
Table 142. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 144. Calithera Biosciences, Inc. Recent Development
Table 145. Chipscreen Biosciences Ltd Corporation Information
Table 146. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Chipscreen Biosciences Ltd Description and Business Overview
Table 148. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 149. Chipscreen Biosciences Ltd Recent Development
Table 150. Deciphera Pharmaceuticals, LLC Corporation Information
Table 151. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Deciphera Pharmaceuticals, LLC Description and Business Overview
Table 153. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 154. Deciphera Pharmaceuticals, LLC Recent Development
Table 155. F. Hoffmann-La Roche Ltd. Corporation Information
Table 156. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 157. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 159. F. Hoffmann-La Roche Ltd. Recent Development
Table 160. Horizon Pharma Plc Corporation Information
Table 161. Horizon Pharma Plc Description and Business Overview
Table 162. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 164. Horizon Pharma Plc Recent Development
Table 165. Immunicum AB Corporation Information
Table 166. Immunicum AB Description and Business Overview
Table 167. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 169. Immunicum AB Recent Development
Table 170. Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
Table 171. Jiangsu Hengrui Medicine Co., Ltd. Description and Business Overview
Table 172. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 174. Jiangsu Hengrui Medicine Co., Ltd. Recent Development
Table 175. Kolltan Pharmaceuticals, Inc. Corporation Information
Table 176. Kolltan Pharmaceuticals, Inc. Description and Business Overview
Table 177. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 179. Kolltan Pharmaceuticals, Inc. Recent Development
Table 180. Natco Pharma Limited Corporation Information
Table 181. Natco Pharma Limited Description and Business Overview
Table 182. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 184. Natco Pharma Limited Recent Development
Table 185. Nerviano Medical Sciences S.r.l. Corporation Information
Table 186. Nerviano Medical Sciences S.r.l. Description and Business Overview
Table 187. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 188. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 189. Nerviano Medical Sciences S.r.l. Recent Development
Table 190. Novartis AG Corporation Information
Table 191. Novartis AG Description and Business Overview
Table 192. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 193. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 194. Novartis AG Recent Development
Table 195. Omeros Corporation Corporation Information
Table 196. Omeros Corporation Description and Business Overview
Table 197. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 198. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 199. Omeros Corporation Recent Development
Table 200. Production Base and Market Concentration Rate of Raw Material
Table 201. Key Suppliers of Raw Materials
Table 202. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
Table 203. Gastrointestinal Stromal Tumor (GIST) Drug Customers List
Table 204. Gastrointestinal Stromal Tumor (GIST) Drug Market Trends
Table 205. Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
Table 206. Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
Table 207. Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastrointestinal Stromal Tumor (GIST) Drug Product Picture
Figure 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Amcasertib Product Picture
Figure 4. Anagrelide hydrochloride CR Product Picture
Figure 5. APG-1351 Product Picture
Figure 6. Binimetinib Product Picture
Figure 7. Others Product Picture
Figure 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application in 2021 & 2027
Figure 9. Clinic Examples
Figure 10. Hospital Examples
Figure 11. Others Examples
Figure 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 20. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Gastrointestinal Stromal Tumor (GIST) Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Gastrointestinal Stromal Tumor (GIST) Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Gastrointestinal Stromal Tumor (GIST) Drug Players Market Share by Revenue in Gastrointestinal Stromal Tumor (GIST) Drug: 2016 & 2020
Figure 31. Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Type (2016-2021)
Figure 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Application (2016-2021)
Figure 35. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type in 2020
Figure 37. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application in 2020
Figure 38. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type in 2020
Figure 39. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application in 2020
Figure 40. China Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type in 2020
Figure 41. China Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application in 2020
Figure 42. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type in 2020
Figure 43. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application in 2020
Figure 44. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type in 2020
Figure 45. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application in 2020
Figure 46. India Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type in 2020
Figure 47. India Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 50. Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 51. Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed